简
/
繁
/
EN
About Us
R&D
Products
News
Careers
Investors
Contact us
Investors
（02186.HK）
HK$
➚
%
Volume(M)
0thousand
Turnover(HK $)
0thousand
Data as of：
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact IR
Year
2022
2023
2024
2025
17
2025-06
VOLUNTARY ANNOUNCEMENT APPROVAL OBTAINED FOR INITIATING CLINICAL TRIALS FOR BA1302 IN THE U.S.
11
2025-06
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
11
2025-06
Next Day Disclosure Return
05
2025-06
Articles of Association
05
2025-06
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
05
2025-06
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 5 JUNE 2025, APPOINTMENT OF EXECUTIVE DIRECTOR AND NON-EXECUTIVE DIRECTOR, CHANGES IN THE COMPOSITION OF BOARD COMMITTEES AND AMENDMENTS OF THE ARTICLES OF ASSOCIATION
05
2025-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
04
2025-06
PLACING OF NEW SHARES UNDER GENERAL MANDATE
07
2025-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
29
2025-04
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 5 JUNE 2025 (APPLICABLE TO HOLDERS OF H SHARES)
1
2
3
4
5
Follow me
鲁公网安备37069102000284